Astria Therapeutics, Inc. announced that it has promoted Andrea Matthews to Chief Business Officer. Ms. Matthews brings 20 years of business experience to the role and has been with the company for close to nine years, most recently as Senior Vice President, Corporate Affairs. Ms. Matthews will be responsible for leading the company's Corporate Strategy, Business Development, Investor Relations, Corporate Communications, and Patient Advocacy functions.

Most recently, she served as Senior Vice President, Corporate Affairs at Astria, since October 2020. Previously, she served as Vice President, Corporate Affairs since 2017, Executive Director, Corporate Affairs since 2015, and Senior Director, Operations and Corporate Development since 2014. Prior to joining Astria, Ms. Matthews served as Vice President, Operations and Alliance Management/Commercial Operations at Selventa (formerly Genstruct) from 2010 and Director, Alliance Management from 2009.

From 2003 to 2009, Ms. Matthews held a series of roles with increasing responsibility at Genstruct. Ms. Matthews holds an M.B.A. from the Massachusetts Institute of Technology Sloan School of Management and a B.A. in Biochemistry and Molecular Biology from Boston University.